Elizabeth Holmes trial: Blood analyzers' failure rates threatened patients, court hears
Briefly

More than a quarter of Theranos' blood analyzers were failing quality control after it started offering blood tests, threatening patients' health, and company founder Elizabeth Holmes was told about problems with the technology, the court heard in Holmes' criminal fraud trial Wednesday.
Read at East Bay Times
[
add
]
[
|
|
]